These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30718242)

  • 1. Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.
    Sopfe J; Pyle L; Keating AK; Campbell K; Liu AK; Wadwa RP; Verneris MR; Giller RH; Forlenza GP
    Blood Adv; 2019 Feb; 3(3):350-359. PubMed ID: 30718242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
    Sopfe J; Campbell K; Keating AK; Pyle L; Liu AK; Verneris MR; Giller RH; Forlenza GP
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28626. PubMed ID: 33480469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients.
    Cho S; Vigers T; Pyle L; Franklin A; Sopfe J; Jeney F; Forlenza G
    Diabetes Technol Ther; 2023 Feb; 25(2):116-121. PubMed ID: 36511871
    [No Abstract]   [Full Text] [Related]  

  • 4. The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.
    Hammer MJ; Casper C; Gooley TA; O'Donnell PV; Boeckh M; Hirsch IB
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):344-51. PubMed ID: 19203725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.
    Sopfe J; Vigers T; Pyle L; Giller RH; Forlenza GP
    Diabetes Technol Ther; 2020 Oct; 22(10):727-733. PubMed ID: 32105513
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT).
    Kaur D; Ashrani AA; Pruthi R; Khan SP; Bailey K; Rodriguez V
    Thromb Res; 2018 Jul; 167():44-49. PubMed ID: 29787942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients.
    Wu JL; Ma HY; Lu CY; Chen JM; Lee PI; Jou ST; Yang YL; Chang HH; Lu MY; Chang LY; Huang LM
    J Microbiol Immunol Infect; 2017 Jun; 50(3):307-313. PubMed ID: 26346369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
    Ahmed I; Teruya J; Murray-Krezan C; Krance R
    Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
    Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
    Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish Pediatric Bone Marrow Transplantation Study Group.
    Hazar V; Karasu GT; Uygun V; Öztürk G; Kiliç SÇ; Küpesiz A; Daloglu H; Aksoylar S; Atay D; Ince EÜ; Karakükçü M; Özbek N; Tayfun F; Kansoy S; Özyürek E; Akçay A; Gürsel O; Haskologlu S; Kaya Z; Yilmaz S; Tanyeli A; Yesilipek A
    Med Mycol; 2019 Feb; 57(2):161-170. PubMed ID: 29608706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid balance of pediatric hematopoietic stem cell transplant recipients and intensive care unit admission.
    Benoit G; Phan V; Duval M; Champagne M; Litalien C; Merouani A
    Pediatr Nephrol; 2007 Mar; 22(3):441-7. PubMed ID: 17123119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
    Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
    Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
    Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients.
    Sheean P; Braunschweig C
    JPEN J Parenter Enteral Nutr; 2006; 30(4):345-50. PubMed ID: 16804133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
    Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malglycemia in the critical care setting. Part III: Temporal patterns, relative potencies, and hospital mortality.
    Roberts GW; Krinsley JS; Preiser JC; Quinn S; Rule PR; Brownlee M; Umpierrez GE; Hirsch IB
    J Crit Care; 2024 Jun; 81():154537. PubMed ID: 38364665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream infection after stem cell transplantation in children with idiopathic aplastic anemia.
    Kobayashi R; Yabe H; Kikuchi A; Kudo K; Yoshida N; Watanabe K; Muramatsu H; Takahashi Y; Inoue M; Koh K; Inagaki J; Okamoto Y; Sakamaki H; Kawa K; Kato K; Suzuki R; Kojima S
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1145-9. PubMed ID: 24727336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.